SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019176
Filing Date
2023-05-09
Accepted
2023-05-09 08:43:45
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q inzy-20230331.htm   iXBRL 10-Q 1561991
2 EX-10.1 inzy-ex10_1.htm EX-10 118397
3 EX-10.2 inzy-ex10_2.htm EX-10 126967
4 EX-10.3 inzy-ex10_3.htm EX-10 92173
5 EX-10.4 inzy-ex10_4.htm EX-10 109363
6 EX-10.5 inzy-ex10_5.htm EX-10 52470
7 EX-10.7 inzy-ex10_7.htm EX-10 104313
8 EX-10.8 inzy-ex10_8.htm EX-10 104964
9 EX-31.1 inzy-ex31_1.htm EX-31 23352
10 EX-31.2 inzy-ex31_2.htm EX-31 23561
11 EX-32.1 inzy-ex32_1.htm EX-32 12026
12 EX-32.2 inzy-ex32_2.htm EX-32 12235
13 GRAPHIC img88664579_0.jpg GRAPHIC 29292
  Complete submission text file 0000950170-23-019176.txt   7115290

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inzy-20230331_pre.xml EX-101.PRE 331647
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inzy-20230331_cal.xml EX-101.CAL 41463
16 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inzy-20230331.xsd EX-101.SCH 44581
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inzy-20230331_def.xml EX-101.DEF 180898
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inzy-20230331_lab.xml EX-101.LAB 445177
64 EXTRACTED XBRL INSTANCE DOCUMENT inzy-20230331_htm.xml XML 942279
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39397 | Film No.: 23900159
SIC: 2834 Pharmaceutical Preparations